18 November 2024 – 12:00
Champalimaud Foundation Auditorium
The Roles of AI in Scientific Discovery: Our Experience Studying Collective Behavio
Gonzalo de Polavieja (Mathematics of Behavior and Intelligence Lab)
Molecular Characterization of Cancer by Spatial Pathology
Mireia Castillo-Martin (Molecular and Experimental Pathology Lab)
Moderator: Ana Luísa Correia (Cancer Dormancy and Immunity Lab)
16 October 2024
“I’m exactly as I was 10 years ago”, says Kina García, a Spanish woman from the Granada region, as she addresses by Zoom, from her home, the audience of the International Conference on Neurodegenerative Diseases, gathered on a Saturday morning at the Champalimaud Foundation’s auditorium, in Lisbon. The date is appropriate: it is September 21 – World Alzheimer's Day.
11 October 2024
Joining institutions such as the Max Planck Society, Germany (#1), the Allen Institute, USA (#6), and the Pasteur Institute, France (#13), the CF's ranking places it among the world’s top contributors to neuroscience, and as the only Portuguese institution to make the list. The ranking is based on its contribution to published research, which is measured by both the number of articles (“Count”) and the portion of authorship (“Share”).
10 October 2024
On the 3rd of October, a full day pre-meeting summit was held on the KPro, the revolutionising keratoprosthesis developed by Claes Dohlman, laureate of the 2022 António Champalimaud Vision Award, receiving it shortly after his 100th birthday. The summit celebrated Dohlman’s legacy with recent advances partly funded by the award and innovative work from around the globe.
05 October 2024
The regatta coincided with Portugal's Implantação da República holiday and the 14th anniversary of the Champalimaud Centre for the Unknown. Boats set sail at 11:00 am, with participants and spectators gathering at the Champalimaud Foundation’s waterfront amphitheatre.
03 October 2024
The conference will present preliminary findings of the Bridge AI project, an ambitious initiative coordinated by INESC-ID, in collaboration with the Champalimaud Foundation and Unbabel. Leading academics, entrepreneurs, policymakers, and interested citizens will gather to discuss the implications and implementation of the European Union’s AI Act.
03 October 2024
With fully functional inpatient and recovery units, as well as operating rooms, the Centre is now prepared to significantly expand the Champalimaud Foundation's capacity to treat pancreatic cancer patients. With a dedicated team of specialists in the treatment and research of this type of cancer, the Centre's mission is to deliver the highest standard of clinical care.